5-((3-Chlorophenyl)amino)benzo[c][2,6]naphthyridine-8-carboxylic acid

Catalog No. :
ACFRVX642
CAS No. :
1009820-21-6
Molecular Formula :
C19H12ClN3O2
Molecular Weight :
349.78

IUPAC Name:5-((3-chlorophenyl)amino)benzo[c][2,6]naphthyridine-8-carboxylic acid

5-((3-Chlorophenyl)amino)benzo[c][2,6]naphthyridine-8-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$79.00Login to see priceIn stockInquiry
100mg98%$97.00Login to see priceIn stockIn stock
250mg98%$162.00Login to see priceIn stockIn stock
1g98%$444.00Login to see priceIn stockIn stock
5g98%$1687.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-((3-Chlorophenyl)amino)benzo[c][2,6]naphthyridine-8-carboxylic acid
IUPAC Name5-((3-chlorophenyl)amino)benzo[c][2,6]naphthyridine-8-carboxylic acid
MDL No.MFCD13184796
Molecular FormulaC19H12ClN3O2
Molecular Weight349.78
SMILESO=C(C1=CC=C2C(N=C(NC3=CC=CC(Cl)=C3)C4=C2C=NC=C4)=C1)O
InChI KeyMUOKSQABCJCOPU-UHFFFAOYSA-N
SynonymPDSP2_000002 | W-204393 | NSC761193 | NSC-761193 | DB15408 | HY-50855 | HMS3244M13 | NCGC00263192-02 | AC-28426 | Q27076934 | silmitasertibum | BENZO(C)-2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID, 5-((3-CHLOROPHENYL)AMINO)- | J-516169 | CX-4945,CAS:1009820-21-6
CAS No.1009820-21-6
PubChem CID24748573

Synthetic Route by SureRoute

1. ACFRVX642 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFRVX642 route product structure diagram
    ACFRVX6421009820-21-6 In Stock
Inquiry

2. ACFRVX642 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFRVX642 route product structure diagram
    ACFRVX6421009820-21-6 In Stock
Inquiry

Comments (0)